Ovillo, Mark Anthony L.

HRN: 08-12-80  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
CO-AMOXICLAV 625MG (TAB)
06/30/2026
07/07/2026
PO
1 Tab
Q 12
ATP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: